Agilent Technologies, Inc.
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Padraig McDonnell
- Full Time Employees
- 17,400
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Address
- 5301 Stevens Creek Boulevard Santa Clara CA United States of America 95051
- IPO Date
- Nov 18, 1999
- CIK
- 0001090872
- Website
- agilent.com
- Similar Companies
- Business
- Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Company News
Agilent to Host Analyst and Investor Day on Dec. 17, 2024
H.I.G. Capital Completes the Sale of BIOVECTRA
Why Is Agilent (A) Up 1.2% Since Last Earnings Report?
Agilent Completes Acquisition of BIOVECTRA
Agilent Announces Cash Dividend of 23.6 Cents per Share
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Airplane engines are in short supply. The business of fixing older ones is booming
Clough Global Equity Fund Section 19(A) Notice
Agilent (A) Reliance on International Sales: What Investors Need to Know
Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi
Agilent (A) Q3 Earnings & Revenues Beat Estimates, Fall Y/Y
These Analysts Boost Their Forecasts On Agilent After Strong Earnings
A Stock Earnings: Agilent Technologies Beats EPS, Beats Revenue for Q3 2024
Agilent Technologies, Inc. (A) Q3 2024 Earnings Call Transcript
Agilent (A) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Agilent Technologies (A) Q3 Earnings and Revenues Beat Estimates
Agilent beats quarterly results on strong demand from biotech clients
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
Agilent (A) Boosts LSAG Segment With J&W 5Q GC/MS Columns
Agilent (A) Set to Report Q3 Earnings: What's in the Offing?